Aytu Biopharma Inc (AYTU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 24,199 | 23,125 | 21,897 | 23,482 | 13,483 |
| Cost of Goods | 11,513 | 10,826 | 9,441 | 12,183 | 13,935 |
| Gross Profit | 12,686 | 12,299 | 12,456 | 11,299 | -452 |
| Operating Expenses | 66,620 | 24,419 | 40,596 | 35,554 | 26,149 |
| Operating Income | -53,421 | -11,294 | -27,699 | -24,072 | -25,666 |
| Other Income | 130 | -257 | -259 | 5,333 | 206 |
| Pre-tax Income | -53,291 | -11,551 | -27,958 | -18,739 | -25,460 |
| Income Tax | N/A | -3 | -107 | N/A | 0 |
| Net Income Continuous | -53,291 | -11,548 | -27,851 | -18,998 | -25,460 |
| Net Income | $-53,291 | $-11,548 | $-27,851 | $-18,998 | $-25,460 |
| EPS Basic Total Ops | -35.90 | -8.74 | -21.76 | -20.00 | -28.20 |
| EPS Basic Continuous Ops | -35.91 | -8.74 | -21.76 | -20.04 | -28.15 |
| EPS Diluted Total Ops | -35.90 | -8.74 | -21.76 | -20.00 | -28.20 |
| EPS Diluted Continuous Ops | -35.91 | -8.74 | -21.76 | -20.04 | -28.15 |
| EBITDA(a) | $-5,593 | $-8,784 | $-5,730 | $-12,369 | $-19,424 |